TRANSFORMING THE WAY WE SEE DISEASE
Elucid Labs™ aims to democratize AI-powered point-of-care medicine by performing digital biopsy.
We are a MedTech startup building the world's first AI-powered computational imaging device that is capable of detection and diagnosis of various diseases without the need for invasive procedures for the purposes of diagnosis and treatment planning. Currently, Elucid is building the world’s first AI dermatology assistant (AIDA™) system for providing clinical decision support as well as productivity tool to medical practitioners for early detection and non-invasive diagnosis of skin cancer and diseases.
AIDA's patent pending computational imaging technology probes the molecular makeup of the skin at different layers and produces a 4000-parameter unique fingerprint for the lesion. AIDA's proprietary deep learning technology translates this fingerprint into valuable clinical knowledge to assist physicians in making better, faster, and well-informed decisions regarding diagnosis and course of treatment.
We are a MedTech startup building the world's first AI-powered computational imaging device that is capable of detection and diagnosis of various diseases without the need for invasive procedures for the purposes of diagnosis and treatment planning. Currently, Elucid is building the world’s first AI dermatology assistant (AIDA™) system for providing clinical decision support as well as productivity tool to medical practitioners for early detection and non-invasive diagnosis of skin cancer and diseases.
AIDA's patent pending computational imaging technology probes the molecular makeup of the skin at different layers and produces a 4000-parameter unique fingerprint for the lesion. AIDA's proprietary deep learning technology translates this fingerprint into valuable clinical knowledge to assist physicians in making better, faster, and well-informed decisions regarding diagnosis and course of treatment.
AS FEATURED IN:
|
|
|
|
Early detection is key to saving lives
AIDA™ combines digital biopsy computational Hypodermoscopy™ imager with an deep learning engine to give clinicians new insights and improves patient experience.
EfficientDetection and diagnosis in a matter of seconds
|
Reduces CostSignificantly reduces unnecessary medical procedures
|
Personalized Healthcare
Enables individuals to proactively participate
|
News timeline
"We want machines and humans to work together, and together we can perform a lot better.”
- Farnoud Kazemzadeh, CEO of elucid labs
PUBLICATIONS
J. Arlette, Alexander Wong, Iman Khodadad, Farnoud Kazemzadeh. Deep Tissue Sequencing Using Augmented Intelligence to Probe Melanocytic Lesions. Journal of Cutaneous Medicine and Surgery. 21(6) 572. 2017. [PDF]
CAREER OPPORTUNITIES
Join Elucid Labs™ in one of the following exciting roles:
There are no roles currently posted.
If you are interested in working at Elucid Labs please email info@elucidlabs.ca
There are no roles currently posted.
If you are interested in working at Elucid Labs please email info@elucidlabs.ca
Contact Us
|
|
|
|
|
Elucid Labs and Hypodermoscopy are trademarks of Elucid Labs Inc.